Relationship Between Adalimumab Concentrations, Antidrug Antibodies, and Disease Activity in Rheumatoid Arthritis: A Cross-Sectional Observational Study.
Lisa K StampPaula E KeatingChristopher M A FramptonMurray L BarclayNiamh C FanningMelanie J MillierPaul A HessianJohn L O'DonnellPublished in: The Journal of rheumatology (2024)
ADA concentration correlates negatively with markers of inflammatory disease activity in RA, including IL-6. ADA concentration in the range 5 to 7 mg/L over the dose interval are associated with better disease control.